Cork’s Solvotrin Therapeutics and Nuance Pharma Partner to launch iron supplement in China 

The partnership aims to achieve €8.6m in retail sales value in three years and was developed by an Irish team of 17 at TCD

Solvotrin Therapeutics’ chief executive Pat O’Flynn, Taoiseach Micheál Martin, and CEO of Nuance Pharma Mark G Lotter in China

The Irish-developed iron supplement brand Active Iron has announced an exclusive agreement to distribute Active Iron in China.

Developers, Cork-based healthcare business Solvotrin Therapeutics, announced an exclusive agreement with Nuance Pharma to distribute Active Iron in China.